Soluble guanylate cyclase stimulators revert in vitro cigarette smoke effects through JNK pathway normalization

A. Bosacoma (Barcelona, Spain), D. Aguilar (Barcelona, Spain), T. Paul (Barcelona, Spain), I. Blanco (Barcelona, Spain), O. Tura-Ceide (Barcelona, Spain), J. Barberà (Barcelona, Spain), V. Peinado (Barcelona, Spain)

Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension
Session: Pathogenesis and pathophysiology of pulmonary hypertension
Session type: E-poster
Number: 590

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Bosacoma (Barcelona, Spain), D. Aguilar (Barcelona, Spain), T. Paul (Barcelona, Spain), I. Blanco (Barcelona, Spain), O. Tura-Ceide (Barcelona, Spain), J. Barberà (Barcelona, Spain), V. Peinado (Barcelona, Spain). Soluble guanylate cyclase stimulators revert in vitro cigarette smoke effects through JNK pathway normalization. 590

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effects of soluble guanylate cyclase (sGC) stimulation in guinea pigs chronically exposed to cigarette smoke
Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and cell biology
Year: 2012

Molecular mechanisms involved in the therapeutic action of the stimulation of soluble guanylate cyclase (sGC) in an experimental model of guinea pig exposed to cigarette smoke
Source: International Congress 2019 – Involvement of the environment and inflammation in pulmonary remodelling
Year: 2019

17-beclomethasone monopropionate or inhibition of MAPK p38 signalling abolish IL-8 release stimulated by cigarette smoke extract or acrolein in normal human airway smooth muscle cells
Source: Annual Congress 2010 - Airway smooth muscle cells
Year: 2010


α,β-unsaturated aldehydes contained in cigarette smoke elicit IL-8 release in pulmonary cells through MAP kinases activation
Source: Annual Congress 2009 - Airway inflammation and host defence
Year: 2009


Soluble guanylyl cyclase expression is reduced in acute lung injury
Source: Eur Respir J 2006; 28: Suppl. 50, 398s
Year: 2006

Cigarette smoke upregulates IL-8/CXCL8 expression by augmenting mRNA stability via p38 MAPK/MK2 signalling in normal human pulmonary cells
Source: Annual Congress 2012 - Basic and translational studies in COPD
Year: 2012


Cigarette smoke exposure disrupts VEGF signalling through the kinase insert-domain receptor (KDR) in rat lungs
Source: Eur Respir J 2004; 24: Suppl. 48, 30s
Year: 2004

Activation of second messenger pathways in alveolar macrophages by endotoxin
Source: Eur Respir J 2002; 20: 210-222
Year: 2002



ERK MAP kinase is upregulated in pulmonary emphysema and mediates MMP-1 induction by cigarette smoke
Source: Eur Respir J 2004; 24: Suppl. 48, 437s
Year: 2004

Cigarette smoke extract (CSE) promotes acetylcholine (ACh) mediated inflammation and oxidative stress by PEBP1/Raf-mediated MEK and ERK pathway in human bronchial epithelial cells
Source: International Congress 2015 – New data on established treatments for asthma and COPD
Year: 2015

Effect of PDE4 inhibitors on MAPK activation and IL-8 production on A549 cells following the induction of oxidative stress
Source: Eur Respir J 2005; 26: Suppl. 49, 99s
Year: 2005

Cilomilast, a second generation phosphodiestease 4 inhibitor, in combination with PGE2 attenuates fMLP, IL-8 and cigarette smoke-induced effects on the mechanical and functional properties of neutrophils
Source: Eur Respir J 2001; 18: Suppl. 33, 161s
Year: 2001

Corticosteroids reduce pro-inflammatory cytokine expression in airway smooth muscle cells via upregulation of MAPK phosphatase-1 and inhibition of p38 MAPK signalling
Source: Eur Respir J 2005; 26: Suppl. 49, 713s
Year: 2005

Effect of non-steroidal anti-inflammatory drugs on neutrophil recruitment, p38 map kinase phosphorylation and NF-κB activation in lung from mice exposed to cigarette smoke
Source: Annual Congress 2007 - Molecular pathogenesis: focus on COPD and asthma
Year: 2007


New drugs for pulmonary hypertension
Source: Eur Respir Mon 2012; 57: 233-246
Year: 2012


Transmission of muscarinic receptor mediated proliferative effects in human lung fibroblasts involves ERK-MAP kinase, but not PI-3 kinase and Rho-kinase pathway
Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology
Year: 2007


Role of the JAK/STAT pathway in activation of the xanthine dehydrogenase/oxidase in lung microvascular endothelial cells exposure to hypoxia
Source: Eur Respir J 2007; 30: Suppl. 51, 145s
Year: 2007

Activation of MAPKs in bronchial-epithelial NCI-H292 cells co-treated with extracellular Hsp70 and bacterial components or cigarette smoke extract
Source: International Congress 2018 – COPD: immune regulation and therapeutic targets
Year: 2018


RAGE blocking ameliorates cigarette smoke extract-induced human alveolar tpye II epithelial cell injury via RAGE-mediated redox sensitive DAMP signaling through Nrf2
Source: International Congress 2018 – COPD: immune regulation and therapeutic targets
Year: 2018

Increased Rho-kinase expression and activity and pulmonary endothelial dysfunction in smokers with normal lung function
Source: Eur Respir J 2011; 37: 349
Year: 2011